Related Experiment Video
Updated: May 14, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Serotypeº1 [corrected] childhood invasive pneumococcal disease has unique characteristics compared to disease caused
Inbal Fuchs1, Ron Dagan, Noga Givon-Lavi
1Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.
Insights
Serotype 1 invasive pneumococcal disease (IPD) is more common in older, Bedouin children and linked to specific conditions like bacteremic pneumonia. This contrasts with other common serotypes (MCS) in IPD cases.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Epidemiology
Background:
- Invasive pneumococcal disease (IPD) is a significant global health concern.
- Distinguishing between different pneumococcal serotypes is crucial for understanding disease patterns and developing targeted interventions.
Purpose of the Study:
- To differentiate serotype 1 (SP1) IPD from IPD caused by other common serotypes (MCS) based on demographic, clinical, and laboratory features.
- To identify unique characteristics associated with SP1-IPD.
Main Methods:
- Retrospective analysis of all pediatric IPD cases (<18 years) at Soroka University Medical Center (2000-2009).
- Comparison of SP1-IPD episodes with MCS-IPD episodes, adjusting for age and ethnicity.
Main Results:
- SP1-IPD cases were older and more prevalent in Bedouin children compared to MCS-IPD.
- SP1 was less common in children with underlying diseases but more frequently associated with bacteremic pneumonia and primary peritonitis.
- No significant differences were observed in hospitalization or mortality rates between SP1-IPD and MCS-IPD.
Conclusions:
- Serotype 1 IPD exhibits distinct demographic and clinical associations compared to other common serotypes.
- SP1-IPD is more prevalent in older and Bedouin children and linked to specific severe presentations like bacteremic pneumonia.
Background:
We aimed to determine whether serotype 1 (SP1) invasive pneumococcal disease (IPD) can be distinguished by demographic, clinical and laboratory characteristics from IPD caused by the other most common serotypes (MCS) in our region: 5, 14, 6A, 6B, 19A, 19F, 23F.
Methods:
Data for all IPD episodes in children <18 years old treated at the Soroka University Medical Center during 2000 to 2009 were retrospectively retrieved. Episodes caused by SP1-IPD were compared with those caused by MCS-IPD (both grouped and individual serotypes). Analyses were adjusted for age and ethnicity.
Results:
Ninety-four SP1-IPD and 250 MCS-IPD episodes were documented. SP1-IPD cases were older (68.3 ± 52.6 months versus 30.4 ± 39.2 months; P < 0.001) and more likely to be found in Bedouin children than MCS-IPD (87.5% versus 58.6%; P < 0.001). SP1 was less frequently isolated from patients with underlying disease than MCS (14.9% versus 31.6 %; P < 0.001; relative risk 0.15 [95% confidence interval: 0.07-0.32]). SP1 was more often associated with bacteremic pneumonia and primary peritonitis than MCS (66% versus 38.4% and 7.4% versus 0.8%, respectively; P < 0.001); the proportion of bacteremia without focus was higher in MCS-IPD (32.4% versus 12.5%; P < 0.001). There were no differences in hospitalization and mortality rates (70.2% versus 68.0% [P = 0.22] and 4.3% versus 5.6% [P = 0.26], respectively).
Conclusions:
SP1 was found less frequently than MCS in children with underlying diseases, but it was more frequent in older and Bedouin children with IPD. SP1 was more frequently associated with bacteremic pneumonia and primary peritonitis than MCS grouped.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

